<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Fairmount Funds Management LLC -->
          <cik>0001802528</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001974640</issuerCik>
      <issuerName>Apogee Therapeutics, Inc.</issuerName>
      <secFileNumber>001-41740</secFileNumber>
      <issuerAddress>
        <com:street1>221 Crescent Street</com:street1>
        <com:street2>Building 17, Suite 102b</com:street2>
        <com:city>Waltham</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02453</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>650-394-5230</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Fairmount Healthcare Fund II L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Jefferies LLC</name>
        <address>
          <com:street1>520 Madison Ave</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>1750000</noOfUnitsSold>
      <aggregateMarketValue>133525000.00</aggregateMarketValue>
      <noOfUnitsOutstanding>54833587</noOfUnitsOutstanding>
      <approxSaleDate>01/22/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>07/13/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Purchased in initial public offering</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>1750000</amountOfSecuritiesAcquired>
      <paymentDate>07/18/2023</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak, who are also directors of the Issuer.</remarks>
    <noticeSignature>
      <noticeDate>01/22/2026</noticeDate>
      <signature>/s/ Tomas Kiselak for Fairmount Funds Management LLC</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
